U.S. Congress Senate Subcommittee on Executive Reorganization of the Committee on
Government Operations: Hearing on the Organization and Coordination of Federal Drug
Research and Regulatory Programs: LSD. 89th Cong., 2nd sess., May 24–26, 1966.
Vollenweider, Franz X., and Michael Kometer. “The Neurobiology of Psychedelic Drugs:
Implications for the Treatment of Mood Disorders.” Nature Reviews Neuroscience 11, no. 9
(2010): 642–51. doi:10.1038/nrn2884.
Vollenweider, Franz X., Margreet F. I. Vollenweider-Scherpenhuyzen, Andreas Bäbler, Helen
Vogel, and Daniel Hell. “Psilocybin Induces Schizophrenia-Like Psychosis in Humans via a
Serotonin-2 Agonist Action.” NeuroReport 9, no. 17 (1998): 3897–902. doi:10.1097/00001756-
199812010-00024.
Wasson, R. Gordon. “Drugs: The Sacred Mushroom.” New York Times, Sept. 26, 1970.
———. “Seeking the Magic Mushroom.” Life, May 13, 1957, 100–120.
Wasson, R. Gordon, Albert Hofmann, and Carl A. P. Ruck. The Road to Eleusis: Unveiling the
Secret of the Mysteries. Berkeley, Calif.: North Atlantic Books, 2008.
Wasson, Valentina Pavlovna, and R. Gordon Wasson. Mushrooms, Russia, and History. Vol. 2.
New York: Pantheon Books, 1957.
Watts, Rosalind, Camilla Day, Jacob Krzanowski, David Nutt, and Robin Carhart-Harris.
“Patients’ Accounts of Increased ‘Connectedness’ and ‘Acceptance’ After Psilocybin for
Treatment-Resistant Depression.” Journal of Humanistic Psychology 57, no. 5 (2017): 520–64.
doi:10.1177/0022167817709585.
Weil, Andrew T. “The Strange Case of the Harvard Drug Scandal.” Look, Nov. 1963.
Whitman, Walt. Leaves of Grass: The First (1855) Edition. New York: Penguin, 1986.
Wit, Harriet de. “Towards a Science of Spiritual Experience.” Psychopharmacology 187, no. 3
(2006): 267. doi:10.1007/s00213-006-0462-8.
Wulf, Andrea. The Invention of Nature: Alexander von Humboldt’s New World. New York: Alfred
A. Knopf, 2015.
frankie
(Frankie)
#1